Major Leading Key Players in the miRNA Sequencing and Assay Market

The miRNA sequencing and assays market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2% during the forecast period. The major driving factors in the miRNA sequencing and assays market are the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing.

Download PDF Brochure:

The major players in the market are Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), and NEB (UK), among others. These players have adopted various growth strategies such as expansions, acquisitions, and product launches to expand their presence in the global miRNA sequencing and assays market. Product launches and collaborations were the most widely adopted growth strategies by major players from 2016 to 2019.

Illumina, a leading player in the market, offers an extensive product portfolio of miRNA sequencing kits and assays. It has a significant presence in more than 100 countries including major markets such as the US, China, Germany, and Japan. Illumina focuses on organic and inorganic growth strategies such as partnerships and collaborations to remain competitive in the market. In the last three years, it collaborated with several companies such as BioRad (US) and Thermo Fisher Scientific (US) as well as introduced a new, smaller, and cheaper NGS platforms such as the iSeq 100.

Request Sample Pages:

Thermo Fisher Scientific is another leading company that provides platforms and sequencing kits in this market. Its ion Torrent platform is the second leading platform in the miRNA sequencing and assays market. The company provides library preparation kits for two of its platforms Ion Torrent and SOLiD. Thermo Fisher is focusing on inorganic growth strategies such as collaborations and partnerships. For example, in 2018, the company entered into a partnership with Illumina that enabled Illumina to sell its product, Ion AmpliSeq technology. The company has a vast geographic presence and operated in 150 countries across the world. Thermo Fisher Scientific has a strong portfolio, which provides it with a competitive advantage in the market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Matched content

Editor’s pick

Do NOT follow this link or you will be banned from the site!